These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 29350283)

  • 1. Epigenetic regulation of neuroblastoma development.
    Durinck K; Speleman F
    Cell Tissue Res; 2018 May; 372(2):309-324. PubMed ID: 29350283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroblastoma and the epigenome.
    Fetahu IS; Taschner-Mandl S
    Cancer Metastasis Rev; 2021 Mar; 40(1):173-189. PubMed ID: 33404859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroblastoma epigenetics: from candidate gene approaches to genome-wide screenings.
    Decock A; Ongenaert M; Vandesompele J; Speleman F
    Epigenetics; 2011 Aug; 6(8):962-70. PubMed ID: 21725203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review: Regulation of the cancer epigenome by long non-coding RNAs.
    Forrest ME; Khalil AM
    Cancer Lett; 2017 Oct; 407():106-112. PubMed ID: 28400335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of epigenetic inactivation of RASSF1A with poor outcome in human neuroblastoma.
    Yang Q; Zage P; Kagan D; Tian Y; Seshadri R; Salwen HR; Liu S; Chlenski A; Cohn SL
    Clin Cancer Res; 2004 Dec; 10(24):8493-500. PubMed ID: 15623630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcription Factors Involved in Tumorigenesis Are Over-Represented in Mutated Active DNA-Binding Sites in Neuroblastoma.
    Capasso M; Lasorsa VA; Cimmino F; Avitabile M; Cantalupo S; Montella A; De Angelis B; Morini M; de Torres C; Castellano A; Locatelli F; Iolascon A
    Cancer Res; 2020 Feb; 80(3):382-393. PubMed ID: 31784426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in the developmental origin of neuroblastoma: an overview.
    Ponzoni M; Bachetti T; Corrias MV; Brignole C; Pastorino F; Calarco E; Bensa V; Giusto E; Ceccherini I; Perri P
    J Exp Clin Cancer Res; 2022 Mar; 41(1):92. PubMed ID: 35277192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic dynamics in normal and malignant B cells: die a hero or live to become a villain.
    Andrews JM; Payton JE
    Curr Opin Immunol; 2019 Apr; 57():15-22. PubMed ID: 30342313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic regulation in human melanoma: past and future.
    Sarkar D; Leung EY; Baguley BC; Finlay GJ; Askarian-Amiri ME
    Epigenetics; 2015; 10(2):103-21. PubMed ID: 25587943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic deregulation of GATA3 in neuroblastoma is associated with increased GATA3 protein expression and with poor outcomes.
    Almutairi B; Charlet J; Dallosso AR; Szemes M; Etchevers HC; Malik KTA; Brown KW
    Sci Rep; 2019 Dec; 9(1):18934. PubMed ID: 31831790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting Chromatin Remodeling for Cancer Therapy.
    Kaur J; Daoud A; Eblen ST
    Curr Mol Pharmacol; 2019; 12(3):215-229. PubMed ID: 30767757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting of epigenetic regulators in neuroblastoma.
    Jubierre L; Jiménez C; Rovira E; Soriano A; Sábado C; Gros L; Llort A; Hladun R; Roma J; Toledo JS; Gallego S; Segura MF
    Exp Mol Med; 2018 Apr; 50(4):1-12. PubMed ID: 29700278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship Between Noncoding RNA Dysregulation and Epigenetic Mechanisms in Cancer.
    Suzuki H; Maruyama R; Yamamoto E; Niinuma T; Kai M
    Adv Exp Med Biol; 2016; 927():109-35. PubMed ID: 27376733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic silencing of prostaglandin E receptor 2 (PTGER2) is associated with progression of neuroblastomas.
    Sugino Y; Misawa A; Inoue J; Kitagawa M; Hosoi H; Sugimoto T; Imoto I; Inazawa J
    Oncogene; 2007 Nov; 26(53):7401-13. PubMed ID: 17533365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic interplays between DNA demethylation and histone methylation for protecting oncogenesis.
    Furuya K; Ikura M; Ikura T
    J Biochem; 2019 Apr; 165(4):297-299. PubMed ID: 30605533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Methylated DNA Immunoprecipitation [MeDIP] to Investigate the Epigenetic Remodeling in Cell Fate Determination and Cancer Development.
    Masciarelli S; Bellissimo T; Iosue I; Fazi F
    Methods Mol Biol; 2016; 1379():69-76. PubMed ID: 26608290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive analysis of epigenetic pattern of long noncoding RNA loci in colorectal cancer.
    Liao Q; Chen L; Liu J; Yang T; Li J; Zhang X; Zhao J
    Gene; 2016 Dec; 595(1):9-17. PubMed ID: 27642123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Origin and initiation mechanisms of neuroblastoma.
    Tsubota S; Kadomatsu K
    Cell Tissue Res; 2018 May; 372(2):211-221. PubMed ID: 29445860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrative Genome-Scale Analysis Identifies Epigenetic Mechanisms of Transcriptional Deregulation in Unfavorable Neuroblastomas.
    Henrich KO; Bender S; Saadati M; Dreidax D; Gartlgruber M; Shao C; Herrmann C; Wiesenfarth M; Parzonka M; Wehrmann L; Fischer M; Duffy DJ; Bell E; Torkov A; Schmezer P; Plass C; Höfer T; Benner A; Pfister SM; Westermann F
    Cancer Res; 2016 Sep; 76(18):5523-37. PubMed ID: 27635046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ARID1A-SIN3A drives retinoic acid-induced neuroblastoma differentiation by transcriptional repression of TERT.
    Bui CB; Le HK; Vu DM; Truong KD; Nguyen NM; Ho MAN; Truong DQ
    Mol Carcinog; 2019 Nov; 58(11):1998-2007. PubMed ID: 31365169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.